Topiramate and cognitive impairment: evidence and clinical implications.

Topiramate and cognitive impairment: evidence and clinical implications.

Item
http://www.wikidata.org/entity/Q38235953
Assessment of cognitive safety in clinical drug developmentNew Pharmacological Agents to Aid Smoking Cessation and Tobacco Harm Reduction: What Has Been Investigated, and What Is in the Pipeline?Chronic antiepileptic drug use and functional network efficiency: A functional magnetic resonance imaging study.Systematic Adverse Drug Reaction Monitoring of Patients Under Newer Antiepileptic Drugs Using Routine Clinical Data of Inpatients.A Common Polymorphism in SCN2A Predicts General Cognitive Ability through Effects on PFC PhysiologyInvestigating psychotropic properties of antiepileptic drugs.Post-epilepsy stroke: A review.Zonisamide Reduces Withdrawal Symptoms But Does Not Enhance Varenicline-Induced Smoking Cessation.Epilepsy and Psychiatric Comorbidities: Drug Selection.Cognitive dysfunction in patients with epilepsy: focus on clinical variables
P2860

Topiramate and cognitive impairment: evidence and clinical implications.

Item
http://www.wikidata.org/entity/Q38235953
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Topiramate and cognitive impairment: evidence and clinical implications.
@en
type
label
Topiramate and cognitive impairment: evidence and clinical implications.
@en
prefLabel
Topiramate and cognitive impairment: evidence and clinical implications.
@en
P1433
P1476
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P932
P356
P1433
P1476
Topiramate and cognitive impairment: evidence and clinical implications.
@en
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P932